Micromet's Unattributed VC - II Round

Micromet raised a round of funding on July 17, 2006. Investors include NGN Capital.

Micromet is focused on biological products for the treatment and control of cancer, inflammatory and autoimmune diseases. Using its antibody technology platforms, Micromet strives to create novel drug…

Articles about Micromet's Unattributed VC - II Round: